Cleared Traditional

K945888 - MODIFIED LUXAR LX-20 FAMILY C02 LASER SYSTEM

K945888 is an FDA 510(k) clearance for MODIFIED LUXAR LX-20 FAMILY C02 LASER S..., manufactured by Luxar Corp.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K945888 · Luxar Corp. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1995
Decision
57d
Days
Class 2
Risk

K945888 is an FDA 510(k) clearance for the MODIFIED LUXAR LX-20 FAMILY C02 LASER SYSTEM. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Luxar Corp. (Bothell, US). The FDA issued a Cleared decision on January 27, 1995 after a review of 57 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Luxar Corp. devices

FDA 510(k) Submission Details - K945888

510(k) Number K945888 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 01, 1994
Decision Date January 27, 1995
Days to Decision 57 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 115d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1805
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K945888.
LASERSPRAY(TM)
K950248 · Biolase Technology, Inc. · Feb 1995
MEGABEAM FIBER OPTIC DELIVERY SYSTEM
K946336 · Hogan & Hartson · Feb 1995
SLT MULTIDIMENSIONAL CONTACT LASER SYSTEM
K931286 · Surgical Laser Technologies, Inc. · Feb 1995
GENERA 100 SURGICAL SYSTEM
K945181 · Xintec Corporation · Jan 1995
ECLIPSE 3200
K945126 · Cardiogenes · Jan 1995
OPTILITE (TM) VII FIBEROPTIC ACCESSORIES ROTALASE (TM) ANGLE DELIVERY SYSTEMSN AND ACCESSORIES
K944704 · Xintec Corporation · Jan 1995